NOVADAQ

NOVADAQ is a medical technology company based in Mississauga, Ontario, Canada, founded in 2000. The company specializes in advanced fluorescence imaging technology that aids surgeons by providing real-time visualization of blood flow and tissue perfusion during surgical procedures. Known for its SPY imaging system, NOVADAQ has established itself as a leader in this field. The core technology of NOVADAQ involves fluorescence imaging using indocyanine green (ICG), a dye that helps visualize blood flow without exposing patients to radiation. This technology is applicable in various surgical fields, including cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive surgeries. The SPY imaging system allows surgeons to assess blood flow quality and tissue perfusion, contributing to improved surgical outcomes. In 2017, NOVADAQ was acquired by Stryker Corporation, enhancing its position in the medical technology market. The company markets its imaging solutions directly and through partnerships, serving hospitals, surgical centers, and healthcare providers worldwide. Its technology is backed by extensive peer-reviewed research demonstrating its clinical benefits.

• Employees 66
• Founded 2000
• Annual Revenue $83420000